AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05207098 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Sociodemographics, Computerized Cognitive Training Programs Questionnaire, CDC Behavioral Risk Factor (Smoking Assessment), Alcohol Consumption CDC, Current Health Rating (KPS), OARS Physical Health section, COVID Medical History, Hospital Anxiety and Depression Scale (HADS), Fatigue Symptom Inventory (FSI), Functional Assessment of Cancer Therapy-General (FACT-G V4), Functional Assessment of Cancer Therapy-Cognition (FACT-Cog V3), Sensory Gating Inventory (SGI)
Study NCT05631548 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: iTBS to dmPFC
Description: TMS will be delivered with a MagVenture Mag Pro R30 with the Cool-B70 A/P coil with active liquid cooling and active/sham sides. Approximately 25% of the nasion-inion distance, or Talairah coordinates X 0 Y+60 Z+60 will be measured.The first session will begin with the acquisition of the resting motor threshold (rMT; lowest stimulus intensity that elicits a visible twitch on 50% of the trials) on the contralateral hand. iTBS (triplet 50 Hz bursts, repeated at 5 Hz, 2 sec on and 8 sec off; 600 pulses per session) will be delivered at 110% of the rMT and will last about 3 minutes. Each participant will receive 2 sessions with a 15-20 minute interval between sessions.
Study NCT05631548 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS to dmPFC
Description: TMS will be delivered with a MagVenture Mag Pro R30 with the Cool-B70 A/P coil with active liquid cooling and active/sham sides. Approximately 25% of the nasion-inion distance, or Talairah coordinates X 0 Y+60 Z+60 will be measured.The first session will begin with the acquisition of the resting motor threshold (rMT; lowest stimulus intensity that elicits a visible twitch on 50% of the trials) on the contralateral hand. iTBS (triplet 50 Hz bursts, repeated at 5 Hz, 2 sec on and 8 sec off; 600 pulses per session) will be delivered at 110% of the rMT and will last about 3 minutes. Each participant will receive 2 sessions with a 15-20 minute interval between sessions.
Study NCT05631548 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham iTBS
Description: Sham TMS will be delivered with the sham side of the MagVenture Cool B70 A/P coil. The software will be pre-programmed by a staff member that will not be involved in data analysis or collection for blinding purposes. The sham stimulation will match the number of pulses and length of time as the active condition and each participant will receive 2 sessions with a 15-20 min interval between sessions.
Study NCT05631548 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham iTBS
Description: Sham TMS will be delivered with the sham side of the MagVenture Cool B70 A/P coil. The software will be pre-programmed by a staff member that will not be involved in data analysis or collection for blinding purposes. The sham stimulation will match the number of pulses and length of time as the active condition and each participant will receive 2 sessions with a 15-20 min interval between sessions.
Study NCT05250193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DK ScoreTM Coronary Scoring Balloon
Description: After pre-dilation balloon is used (if any), DK Score is used as final dilatation balloon before Drug Eluting Stent implantation or Drug Coated Balloon deployment.
Study NCT05250193 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-Slip Element Coronary Dilatation Catheter
Description: After pre-dilation balloon is used (if any), NSE is used as final dilatation balloon before Drug Eluting Stent implantation or Drug Coated Balloon deployment.
Study NCT05677191 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Proximal Femoral Nail
Description: open reduction
Study NCT05677191 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Dual Mobility Arthroplasty
Description: Hip Arthroplasty Surgery
Study NCT05551598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride Liposome Injection
Description: IV, once every 12 weeks (Q12W)
Study NCT06206824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucettinib-21
Description: See arm's description.
Study NCT05551598 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mitoxantrone Hydrochloride Liposome Injection
Description: IV, once every 12 weeks (Q12W)
Study NCT05628025 — intervention group
Intervention type: OTHER
Intervention: Organ phantom of prostate
Description: Participants will operate on a 3D printed model of the prostate.
Study NCT05429554 — intervention group
Intervention type: DRUG
Intervention: Vildagliptin
Description: observe the effect of vildagliptin on cognitive function and cardiovascular in diabetic patients
Study NCT05122546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib S-malate
Description: Given PO
Study NCT05122546 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cabozantinib S-malate
Description: Given PO
Study NCT04989777 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IABP (Intra-aortic balloon pump ) implantation
Description: Eligible AMI patients in SCAI-B stage will receive IABP implantation from the femoral artery
Study NCT05122546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clostridium butyricum CBM 588 Probiotic Strain
Description: Given PO
Study NCT05122546 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT05122546 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab
Description: Given IV
Study NCT05222542 — intervention group
Intervention type: OTHER
Intervention: Sampling of plasma and cerebrospinal fluid at specified time points
Description: Samples (plasma, and in patients with in-dwelling cerebrospinal fluid drainages also cerebrospinal fluid) will be taken within 72 hours of subarachnoid hemorrhage and 7, 14 and 21 days following initial bleeding. Another plasma sample will be obtained if an antihypertensive therapy with a RAS modifying drug has been started.
Study NCT05343598 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry.~The rTMS pulses will be delivered in a pattern consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz every 10s for 600 total pulses.
Study NCT05343598 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry.~The rTMS pulses will be delivered in a pattern consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz every 10s for 600 total pulses.~Sham is achieved by using a coil with a magnetic shield preventing magnetic field from reaching the head.
Study NCT05613517 — intervention group
Intervention type: OTHER
Intervention: Eye examination
Description: * orthoptic assessment (visual acuity, refraction, stereopsis test, Cover-test, evaluation of the disparity of fixation and ocular dominance, measurement of the inter-pupillary distance~* ocular biometry~* corneal topography~* monocular photographs in photopic condition
Study NCT05880121 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: brain MRI
Study NCT01211782 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: caprylic triglyceride
Description: oral, 20 gm, daily x 6 months
Study NCT01211782 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: long-chain triglyceride
Description: oral, 14 gm, daily x 6 months
Study NCT06312514 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LAFIYA
Description: The Lafiya intervention is a comprehensive program designed to address the intersectional stigma and discrimination challenges faced by marginalized communities, particularly among Gay, Bisexual, and other Men who have Sex with Men (GBMSM). It aims to enhance HIV prevention, care, and treatment outcomes, with a focus on increasing HIV self-testing (HIVST) uptake among these key populations in Ghanaian urban slum settings.
Study NCT05496777 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Home-based prehabilitation program
Description: The home-based prehabilitation program will consist of a four-week program, where patients are expected to perform a high-intensity interval training on a home-trainer combined with functional mobility training three times a week. The program is partly supervised by a trained physiotherapist.
Study NCT04242147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KD033 (SAR445710)
Description: Pharmaceutical form: Solution for infusion Route of administration: intravenous (IV)
Study NCT06089993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The total volume of exercise is 40 repetitions of each of the 4 exercises. The participant is instructed to perform a maximum of 10 repetitions each set, with 1'30'' rest between sets and between exercises. The researcher provides instructions and verbal encouragement. The total duration of the exercise bout is between 1 hour and 1 hour and 15 minutes.~Part 1: Before and after the exercise condition the participant is sampling 8 different samples: (1) sucrose (2) umami (3) soy protein (4) pea protein (5) hemp protein (6) brown rice (7) whey protein and (8) apple juice.~All protein sources are 3 grams dissolved in 20ml apple juice. Sucrose is 1.66g in 20ml water and umami tastant is 0.09g in 20ml water.~Part 2: a 30g soy protein bolus in 200ml apple juice is given to the participant. After 1 hour energy intake is assessed with an ad libitum lunch meal.
Study NCT06089993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rest
Description: The participant remains in sedentary activities such as reading or using a laptop.~Part 1: Before and after the rest condition the participant is sampling 8 different samples: (1) sucrose (2) umami (3) soy protein (4) pea protein (5) hemp protein (6) brown rice (7) whey protein and (8) apple juice.~All protein sources are 3 grams dissolved in 20ml apple juice. Sucrose is 1.66g in 20ml water and umami tastant is 0.09g in 20ml water.~Part 2: a 30g soy protein bolus in 200ml apple juice is given to the participant. After 1 hour energy intake is assessed with an ad libitum lunch meal.
Study NCT05419856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4P-004
Description: single intraarticular administration in the knee joint
Study NCT05404776 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placement of Foley balloon for cervical ripening with tension.
Description: A Foley balloon will be placed for cervical ripening with tension.
Study NCT05404776 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placement of Foley balloon for cervical ripening without tension.
Description: A Foley balloon will be placed for cervical ripening without tension.
Study NCT05419856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: single intraarticular administration in the knee joint
Study NCT06311591 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Jaspr App
Description: Jaspr was designed to improve delivery of evidence-based, personalized suicide care in the ED. Jaspr (Dimeff, R44MH108222) is rooted in EBPs, including Collaborative Assessment and Management of Suicide (CAMS) and Dialectical Behavior Therapy (DBT). Briefly, Jaspr provides a patient interface, optimized for a tablet computer provided to the patient, which uses an avatar to administer: (1) the CAMS Suicide Status Form (SSF), an evidence-based suicide risk assessment; (2) crisis stabilization planning (CAMS' version of safety planning) or Stanley-Brown Safety Planning Intervention, depending on site choice; (3) lethal means safety counseling. Further, Jaspr teaches behavioral skills from DBT to manage imminent distress and has a library of over 40 racially and culturally diverse, inspirational videos of people with lived experience. Finally, Jaspr@home provides access to these resources after the visit during the high-risk transition to outpatient care.
Study NCT05622578 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: QST, CPM and Paisudoscan
Description: Quantified pain tests
Study NCT05500105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simple cognitive task intervention
Description: Session 1: A memory cue followed by playing the computer game Tetris (e.g. on own smartphone) with mental rotation instructions.~Options to engage in self-administered/guided booster sessions per intrusive memory.
Study NCT05722587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain science education
Description: High school students receiving a day of pain science education in multiple formats, lectures, experiential, completing a task which consolidates the information.
Study NCT06145594 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EMA Monitoring
Description: Weekly prompts to participants' smart phones for collection of PHQ-9 data
Study NCT06145594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EMA Monitoring
Description: Weekly prompts to participants' smart phones for collection of PHQ-9 data
Study NCT06145594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scheduling Maintenance TMS sessions
Description: When threshold score is reached, the participants is offered TMS maintenance treatments
Study NCT06387082 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMPL-506
Description: HMPL-506 will be administered orally in 28-day cycles, until disease progression/relapse , death, intolerable toxicity, receipt of another anti-tumor therapy (including HSCT), failure to further benefit , patient withdrawal, loss to follow-up or end of the study, whichever comes first.
Study NCT05678426 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Description: Smoking cessation encompasses three guided smoking cessation group therapy sessions (6-12 participants per session) followed by smoking cessation (occuring in the second session) for 6 months. Participants receive an optional exercise programme and motivational coaching over the duration of the study.
Study NCT05678426 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intermittent fasting
Description: The dietary intervention encompasses induction (1 month) and maintenance (5 months) of a 16:8 intermittent fasting regime (time restricted eating to 8 h a day, fasting for remaining 16 h). During the introductory month, participants will only maintain a 14:10 intermittent fasting regime. Participants receive an optional exercise programme and motivational coaching over the duration of the study.
Study NCT05678426 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intermittent fasting with ketogenic supplement
Description: The dietary intervention encompasses induction (1 month) and maintenance (5 months) of a 16:8 intermittent fasting regime (time restricted eating to 8 h a day, fasting for remaining 16 h). During the introductory month, participants will only maintain a 14:10 intermittent fasting regime. Participants receive a ketogenic supplement, medium-chain triglyceride fiber, to use daily. Participants receive an optional exercise programme and motivational coaching over the duration of the study.
Study NCT04650581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipatasertib
Description: 400 mg PO QD days 1-21 every 28 days
Study NCT04650581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: 500 mg IM cycle 1 days 1 and 15 followed by 500 mg IM day 1 q 28 days subsequent cycles
Study NCT04650581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fulvestrant
Description: 500 mg IM cycle 1 days 1 and 15 followed by 500 mg IM day 1 q 28 days subsequent cycles
Study NCT04650581 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: PO QD days 1-21 every 28 days
Study NCT05918445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PM8002
Description: IV infusion
Study NCT04681144 — intervention group
Intervention type: DRUG
Intervention: Radium-223-dichloride (Xofigo, BAY88-8223)
Description: Decision to initiate treatment with Radium-223 made as per investigator's routine treatment practice
Study NCT05532969 — intervention group
Intervention type: OTHER
Intervention: stressors
Description: Patients are exposed to stressful situations related to the diagnosis and treatment of the disease
Study NCT05945888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 3000202
Description: BI 3000202
Study NCT05945888 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching BI 3000202
Description: Placebo matching BI 3000202
Study NCT05049863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: Mycophenolate mofetil is commercially available.
Study NCT05049863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allopurinol
Description: Allopurinol is commercially available.
Study NCT05589441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: salbutamol
Description: 10 mg salbutamol diluted to 2 ml with distilled water and inhaled as aerosolized for 15 min before the start of the hepatic-free phase.
Study NCT05589441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin
Description: Intravenous injection of 8U of insulin complex 10% glucose solution 250 ml before the start of the hepatic phase was completed in 15 minutes.
Study NCT05049863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Irinotecan is commercially available.
Study NCT04812925 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: efgartigimod PH20 SC
Description: Subcutaneous injection with efgartigimod PH20 SC
Study NCT05236036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: Given PO
Study NCT05236036 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05236036 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Receive radiation therapy
Study NCT05236036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given Orally (PO)
Study NCT05089292 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative breast health education
Description: Health education program utilizing narrative messages to promote breast cancer screening in Chinese immigrant women will be delivered in a group format in the community
Study NCT05119764 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual Lymphatic Drainage
Description: Manual Lymphatic Drainage is a form of physical therapy with the primary goal of accelerating lymphatic drainage.~In this study, the manual lymphatic drainage is applied by experienced physical therapists 5 days in a row for 30 minutes each; after and/or before the surgery.
Study NCT05492409 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GNR-069
Description: Once a week as a subcutaneous injection.
Study NCT05622123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-NODAGA-Exendin-4
Description: PET/CT imaging after injection with 68Ga-NODAGA-exendin-4
Study NCT06520137 — intervention group
Intervention type: PROCEDURE
Intervention: Tooth extraction
Description: Extraction of maxillary third molars
Study NCT05146375 — intervention group
Intervention type: BIOLOGICAL
Intervention: TGFBR2
Description: TGFBR2 mutation correlation with severity of the aortic disease. Blood sampling. Serum will be analysed by DNA sequencing to detect specific mutations involved in aneurysms.~Cutaneous biopsy. Fibroblast culture will be done to assess the transcriptome analysis.
Study NCT05223517 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Hwato brand disposable acupuncture needles (size 0.30 × 40 mm and 0.30 × 75 mm) and adhesive pads will be used. Acupoints of Ciliao, Huiyang, Shenshu, Guanyuan, Shuidao, Sanyinjiao, Zusanli, Taixi, Hegu, and Taichong will be used for every participants. Those with sleep or mood disorders will also use acupoints of Shangyintang, Shenmen and Neiguan. Those with tenderness points on the abdominal wall will also use Ashi points no more than five.~The needles will be inserted to 60-70mm in Ciliao and Huiyang, 6-10 mm in Shenmen and 10-20mm in other acupoints through adhesive pads. Needles will be lifted, thrusted and twirled gently for 3 times (except for Ciliao) to achieve deqi sensation and manipulated every ten minutes during 20-minute maintenance in prone and supine position respectively.~Participants receive acupuncture treatment three times a week in the first four weeks and twice a week in the last four weeks.